Pillstats
Rx only · Injection, Powder, For Solution · Intravenous

Piperacillin And Tazobactam

Piperacillin Sodium + Tazobactam Sodium

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US22 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)8339
US makers9 labelers
Packages24
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 3 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$1.00$2.01$3.01$4.02Dec 2025Jan 2026Jan 2026
$3.493
Latest avg · Jan 21, 2026
+2%
Since Dec 17, 2025
9
Active US suppliers
29%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

4.4K8.8K13K18K2025 Q12025 Q22025 Q32025 Q42026 Q1
13K
Rx · 2026 Q1
84K
Units dispensed
-3%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Avenacy, LLCunknown4SUPPLYING
Fresenius Kabi USA, LLCunknown3SUPPLYING
ONESOURCE SPECIALTY PHARMA LIMITEDunknown3SUPPLYING
Shandong Anxin Pharmaceutical Co., Ltd.unknown3SUPPLYING
Apotex Corp.unknown3SUPPLYING
BluePoint Laboratoriesunknown3SUPPLYING
Armas Pharmaceuticals Inc.unknown2SUPPLYING
Civica, Inc.unknown2SUPPLYING
WG Critical Care, LLCunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.